An evaluation of policies and procedures of successful pharmaceutical exporters and the comparison of Iranian counterpart policy
Background: The volume of the global pharmaceutical market reached 956 billion US dollars in 2011. The reported volume of global exported pharmaceutical products in 2010 exceeds $585 billion. Despite the potential of the market and the suitable geographical location, the volume of Iran's pharma...
Saved in:
Main Authors: | Meysam Seyedifar (Author), Shokufeh Nikfar (Author), Akbar Abdollahi-Asl (Author), HamidReza Rasekh (Author), Ashkan Ehsani (Author), Abbas Kebriaeezadeh (Author) |
---|---|
Format: | Book |
Published: |
Tehran University of Medical Sciences,
2015-10-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
From generic scheme to brand-generic scheme: Have new policy influenced the efficiency of Iranian pharmaceutical companies?
by: Amir Hashemi-Meshkini, et al.
Published: (2014) -
Export Readiness Assessment of Ten Iranian Pharmaceutical Companies and Comparison with their Export Performance
by: Mehdi Mohammadzadeh, Mohammad Poloee, Tayebeh Ghari
Published: (2016) -
Monitoring of National Drug Policy (NDP) and its standardized indicators; conformity to decisions of the national drug selecting committee in Iran
by: Abdollahi Mohammad, et al.
Published: (2005) -
The Relationship Between Quality Assurance Structure and Profitability in Iranian Pharmaceutical Industries
by: Abbas Kebriaeezade, et al.
Published: (2021) -
Iranian Pharmaceutical Industry Opportunities in Iraq
by: Ahmed Hayder Mohsin Al Iami, et al.
Published: (2019)